ARCHIVES

NCI-Approved Clinical Trials

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

Tafinlar Subgroup Data Shows Median OS of 20 Months

October 31, 2014

NCI Programs: New RAID Program Offers NCI Expertise In Drug Development

April 24, 1998

2,000 Breast Cancer Recurrence Biomarker Candidates Discovered

August 31, 2012

DCE Board Approves Study of Breast Cancer On Long Island

June 17, 1994

DCAB Board Okays One Contract Concept, Sends Another Back to Drawing Board

May 22, 1981

Propac To Recommend Reclassification Of Five Leukemia/Lymphoma Diagnosis Related Groups

March 21, 1986